Sirtuin 1 (SIRT1), an NAD + -dependent deacetylase involved in lipid metabolism, has been proposed as a potential therapeutic target for treating obesity-related metabolic disturbance [12, 13]
As part of the evolving R&D pipeline, Figure 3 summarises the emerging research frontiers into the potential therapeutic applications of GLP-1s beyond cardiometabolic conditions, including neurodegeneration, addiction, mental health, cancer, womens health and asthma
This takes on the classic butterfly rash shape associated with SLE
Doctors Support GOLO Over 5,000 doctors have recommended GOLO to their patients.** GOLO is not only a healthy and sustainable weight loss solution, but also helps to lower health risk markers, is safe to use with medications, and has proven clinical results
Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-B pathways
DKA usually occurs when there is inadequate insulin in the body
